CD8A and neoplasm: Cross-priming, a process which DCs prime CD8 T cells following cross-presentation of exogenous antigens onto MHCI [24,25], plays a critical role in inducing anti-tumor CD8 T cell immunity as well as mediating CD8 T cell tolerance (cross-tolerance) [26,27,28,29].